Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

8.115
-0.250-2.99%
Volume:1.16M
Turnover:9.40M
Market Cap:8.54B
PE:-18.74
High:8.300
Open:8.250
Low:7.675
Close:8.365
52wk High:19.860
52wk Low:7.675
Shares:1.05B
HK Float Shares:1.05B
Volume Ratio:0.88
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.433
ROE:-28.59%
ROA:-19.64%
PB:3.21
PE(LYR):-18.74
PS:7704.41

Loading ...

OverviewCompanyNewsFilings

Analysts Are Optimistic We'll See A Profit From Ascletis Pharma Inc. (HKG:1672)

Simply Wall St.
·
Apr 09

ASCLETIS-B Maintains Stable Share Base in March; No New Issuance, Public Float Fully Compliant

Bulletin Express
·
Apr 08

ASCLETIS-B Advances Clinical Development of Fixed-Dose Combination ASC30_39 for Obesity Treatment

Stock News
·
Apr 07

BRIEF-Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

Reuters
·
Apr 07

Ascletis Accelerates Obesity Pipeline with First-in-Class Oral GLP-1/Amylin Fixed-Dose Combo; IND Targeted for Q3 2026

Bulletin Express
·
Apr 07

Ascletis Pharma Inc - Expects Ind Submission to FDA for Asc30_39 Fdc in Q3 2026

THOMSON REUTERS
·
Apr 07

Ascletis targets Q3 2026 FDA IND filing for oral obesity combo ASC30_39 tablet

Reuters
·
Apr 07

Analyst Rate

Buy
Buy
75.00%
Hold
25.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 31, 2026
Financial Report Announcement
Mar 31, 2026 Post-Mkt
Financial Report Announcement
Aug 15, 2025
Financial Report Announcement
Mar 26, 2025 Pre-MKt
Financial Report Announcement
Aug 30, 2024

Dividend History

no data

No relevant data is available

Valuation Analysis

-11.86
Current
-18.73
Sector Average
56.84%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-11.86
Maximum
-3.06
+1 STD
-4.87
Minimum
-64.07
-1 STD
-32.58
Average
-18.73

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.